Last reviewed · How we verify
NCT07163169
Predicting Chemo Toxicity Using Geriatric Forms
trial in Oncology in 150 participants. Participants enrolled and being followed up; not accepting new ones.
20 December 2025
Quick facts
| Lead sponsor | Çanakkale Onsekiz Mart University |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 10 December 2024 |
| Primary completion | 20 December 2025 |
| Estimated completion | 20 December 2026 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Oncology — all drugs for Oncology →
- Geriatric Oncology — all drugs for Geriatric Oncology →
- Physiology — all drugs for Physiology →
Sponsor
Çanakkale Onsekiz Mart University
Who can join
65 and older, any sex, with Oncology or Geriatric Oncology. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This prospective observational study aims to evaluate and compare the effectiveness of three geriatric assessment tools-CARG (Cancer and Aging Research Group score), G8 screening tool, and Frailty Scale-in predicting chemotherapy-related toxicity (CRT) in cancer patients aged 65 years and older. A total of at least 100 patients receiving standard chemotherapy (excluding hematologic malignancies and immunotherapy) at Çanakkale University Medical Faculty Oncology Clinic will be assessed prior to treatment initiation. Each participant will undergo baseline evaluations including G8, CARG, and Frailty assessments. The study will analyze the correlation between these tools and the occurrence of CRT using AUC, logistic regression, and correlation analyses. The goal is to identify the most accurate and practical screening tool to guide clinical decision-making and minimize chemotherapy toxicity in older adults.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07163169
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Oncology
Currently open trials in the same condition.
- NCT07341464 — Acceptability and Tolerance Study of Bolus Tube Feed With Food Blends · NA · recruiting
- NCT07262632 — Developing a Multimodal Cancer Pain Database to Support AI-Based Automatic Pain Assessment · recruiting
- NCT06868524 — Leading Healthy Eating and Activity Promotion Program · NA · recruiting
- NCT06959810 — Impact of Adapted Aesthetic Onco in Patients With Upper Aerodigestive Tract Cancer During Their Management · NA · recruiting
- NCT06950073 — Curatively Intended Thoracic Reirradiation · recruiting
Other Çanakkale Onsekiz Mart University trials
Trials by the same sponsor.
- NCT07520552 — Comparison of Lateral Internal Sphincterotomy Techniques for Chronic Anal Fissure · NA · not yet recruiting
- NCT07521527 — i-PRF for Gingival Phenotype Modification · NA · active not recruiting
- NCT07530471 — Autologous Blood Products in Ridge Preservation · NA · active not recruiting
- NCT07359365 — The Effect of Breathing Exercises on Compassion Fatigue and Work Tress Among Emergency Department Nurses · NA · not yet recruiting
- NCT07462221 — Effect of Telenursing on Oral Health · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07163169 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Çanakkale Onsekiz Mart University
- Last refreshed: 9 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07163169.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing